Description
Demodex (Metronidazole) 50 ml
Ingredients
Metronidazole
Mechanism of Action
Metronidazole disrupts the DNA structure of Demodex mites, leading to their death. This mechanism helps in reducing the mite population on the skin and alleviating symptoms such as itching and redness.
Pharmacological Properties
Metronidazole has demonstrated efficacy in targeting Demodex mites on the skin, resulting in a reduction in mite populations and improvement in associated symptoms.
Indications for Use
Demodex (Metronidazole) 50 ml is indicated for the treatment of Demodex infestation on the skin.
Contraindications
Do not use Demodex (Metronidazole) 50 ml if allergic to metronidazole or any other ingredients in the product.
Side Effects
Common side effects may include skin irritation or redness at the application site. Consult a healthcare professional if any adverse reactions occur.
Usage Instructions
For external use only. Apply a thin layer to the affected area once daily. Avoid contact with eyes and mucous membranes.
Benefits Compared to Analogues
Metronidazole has shown efficacy in targeting Demodex mites specifically, making it a suitable choice for treating Demodex infestations with proven effectiveness.
Suitable Patient Groups
Demodex (Metronidazole) 50 ml is suitable for adult patients with Demodex infestations. Consult a healthcare provider for use in children or elderly individuals.
Storage Conditions and Shelf Life
Store Demodex (Metronidazole) 50 ml in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use after the specified date.
Packaging Description
Demodex (Metronidazole) 50 ml is packaged in a sealed container to maintain product integrity and prevent contamination.
Clinical Evidence and Proven Effectiveness
Metronidazole has been clinically proven to effectively reduce Demodex mite populations on the skin and improve symptoms associated with Demodex infestations. Clinical trials have shown significant reductions in mite density and skin symptom improvement with metronidazole-based treatments.
